Solbar Ningbo Protein Technology Co., Ltd. (SHA:603231)
China · Delayed Price · Currency is CNY 18.71
+0.01 (0.05%)
Feb 13, 2026, 3:00 PM CST
SHA:603231 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,634 | 1,549 | 1,740 | 1,839 | 1,580 | 1,274 |
Other Revenue | 6.08 | 6.08 | 8.49 | 7.93 | 6.41 | 4.93 |
| 1,641 | 1,555 | 1,748 | 1,847 | 1,586 | 1,279 | |
Revenue Growth (YoY) | 1.60% | -11.04% | -5.33% | 16.44% | 24.05% | 20.25% |
Cost of Revenue | 1,364 | 1,373 | 1,512 | 1,603 | 1,364 | 1,094 |
Gross Profit | 276.66 | 182.7 | 236.62 | 243.89 | 222.02 | 184.11 |
Selling, General & Admin | 69.55 | 61.8 | 55.4 | 47.26 | 46.3 | 49.2 |
Research & Development | 7.79 | 10.41 | 10.45 | 12.24 | 12.39 | 11.15 |
Other Operating Expenses | 5.47 | -4.13 | 5.85 | 6.74 | 4.78 | 5.77 |
Operating Expenses | 87.22 | 67.27 | 73.05 | 67.36 | 68.25 | 65.35 |
Operating Income | 189.43 | 115.42 | 163.56 | 176.52 | 153.77 | 118.76 |
Interest Expense | -0.08 | -0.14 | -2.56 | -5.69 | -2.44 | -2.4 |
Interest & Investment Income | 3.07 | 12.07 | 0.66 | 0.09 | 0.34 | 6.7 |
Currency Exchange Gain (Loss) | 6.54 | 6.54 | 2.1 | 13.19 | -2.88 | -5.96 |
Other Non Operating Income (Expenses) | 4.97 | 3.44 | -0.17 | -0.39 | -0.48 | -0.39 |
EBT Excluding Unusual Items | 203.93 | 137.34 | 163.6 | 183.71 | 148.31 | 116.72 |
Gain (Loss) on Sale of Investments | 8.15 | 6.2 | - | -0.45 | -0.53 | 1.42 |
Gain (Loss) on Sale of Assets | -3.26 | -0.03 | 0.35 | 0.54 | - | 0.07 |
Asset Writedown | -2.85 | -2.86 | -4.39 | -3.03 | -9.88 | -9.28 |
Legal Settlements | - | - | -2.94 | -0.41 | -0.12 | -0.08 |
Other Unusual Items | 3.64 | 3.41 | 15.63 | 8.21 | 4.75 | 10.55 |
Pretax Income | 209.63 | 144.08 | 172.25 | 188.81 | 142.54 | 119.55 |
Income Tax Expense | 33.44 | 22.9 | 26.26 | 20.79 | 18.6 | 21.81 |
Net Income | 176.19 | 121.18 | 145.98 | 168.03 | 123.94 | 97.75 |
Net Income to Common | 176.19 | 121.18 | 145.98 | 168.03 | 123.94 | 97.75 |
Net Income Growth | 44.45% | -16.99% | -13.12% | 35.57% | 26.80% | 48.12% |
Shares Outstanding (Basic) | 192 | 192 | 139 | 144 | 144 | 144 |
Shares Outstanding (Diluted) | 192 | 192 | 139 | 144 | 144 | 144 |
Shares Change (YoY) | 9.60% | 38.35% | -3.19% | -0.35% | 0.26% | 24.16% |
EPS (Basic) | 0.92 | 0.63 | 1.05 | 1.17 | 0.86 | 0.68 |
EPS (Diluted) | 0.92 | 0.63 | 1.05 | 1.17 | 0.86 | 0.68 |
EPS Growth | 31.80% | -40.00% | -10.26% | 36.05% | 26.47% | 19.30% |
Free Cash Flow | -43.37 | -20.83 | 44.2 | 42.27 | 1.26 | 125.27 |
Free Cash Flow Per Share | -0.23 | -0.11 | 0.32 | 0.29 | 0.01 | 0.87 |
Dividend Per Share | 0.370 | 0.300 | 0.500 | 0.300 | 0.400 | 0.500 |
Dividend Growth | -26.00% | -40.00% | 66.67% | -25.00% | -20.00% | 150.00% |
Gross Margin | 16.86% | 11.75% | 13.53% | 13.21% | 14.00% | 14.40% |
Operating Margin | 11.55% | 7.42% | 9.35% | 9.56% | 9.70% | 9.29% |
Profit Margin | 10.74% | 7.79% | 8.35% | 9.10% | 7.81% | 7.65% |
Free Cash Flow Margin | -2.64% | -1.34% | 2.53% | 2.29% | 0.08% | 9.80% |
EBITDA | 259.26 | 182.24 | 226.37 | 228.47 | 198.35 | 162.39 |
EBITDA Margin | 15.80% | 11.72% | 12.95% | 12.37% | 12.51% | 12.70% |
D&A For EBITDA | 69.82 | 66.82 | 62.81 | 51.94 | 44.58 | 43.63 |
EBIT | 189.43 | 115.42 | 163.56 | 176.52 | 153.77 | 118.76 |
EBIT Margin | 11.55% | 7.42% | 9.35% | 9.56% | 9.70% | 9.29% |
Effective Tax Rate | 15.95% | 15.90% | 15.25% | 11.01% | 13.05% | 18.24% |
Revenue as Reported | 1,641 | 1,555 | 1,748 | 1,847 | - | - |
Advertising Expenses | - | 1.48 | 0.83 | 0.54 | 0.55 | 0.53 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.